We're excited to be back in New Orleans and hosting the New Orleans Health Fair! The FREE event will feature:

📋 Heart Health Screenings
✏️ Education Sessions
➕ More

Join Dr. Nausheen Akhter on Saturday, March 21, 10 am-2 pm CT. Learn more 🔗 https://bit.ly/3ZGhZQv #ACCHealthEquity #CardioSky #MedSky

Among patients undergoing coronary angiography (CAG), using virtual reality during the procedure relieved anxiety and promoted more stable vital signs, according to research presented during #ACCMidEast.

Read more: https://bit.ly/4pWqbb3

#ACCIntl #CardioSky #MedSky

Don’t miss your chance to share your research with the global cardiovascular community at #ACC26 in New Orleans, March 28 – 30, 2026.

The deadline for abstract and case submissions is Tuesday, Sept. 30 at 1 p.m. ET! ➡️ https://bit.ly/4pH6yn6

#CardioSky #MedSky

Maternal Gestational Diabetes Is Associated With Offspring’s Hypertension AbstractOBJECTIVE. Several studies assessed maternal gestational diabetes mellitus (GDM) with the risk of childhood high blood pressure, and the results we

#WeekendReads from #EditorsChoice

Maternal Gestational Diabetes and Offspring Incidence of Hypertension

academic.oup.com/ajh/article/...

#Free

Acoramidis 📉 cumulative CV outcomes in #ATTRCM vs placebo, w/ numerical differences by month 1 & 📈 through month 30 (53 events avoided/100 pts). Nearly 1/4 of events occurred in the first 6 months, underscoring the need for timely Tx https://bit.ly/4gLv5DG

#HFSA2025 #JACC #CardioSky

JAMA image titled, "Partial Heart Transplant for Congenital Heart Disease." It includes two bar graphs showing annulus diameters of transplanted aortic and pulmonary valves over time. Baseline and follow-up changes are highlighted.

Partial heart transplant appears to be a viable and safe solution for growing valve replacement in congenital heart disease, addressing the limitations of current nongrowing valve options.

ja.ma/48AzcAb

AI is changing everything—even heart failure care. 💡
Hear how at the JCF Central Lecture Series with Dr. Jonathan W. Cunningham & Dr. Nir Uriel.

📅 Sept. 28 | ⏰ 1:45–2:15pm

Evolocumab after #CABG did not 🚫 reduce SVG disease rates at 2️⃣ years when compared with placebo, based on findings from the NEWTON-CABG CardioLink-5 trial presented at #ESCCongress. Details: https://bit.ly/4p2Vfp7

Does surgical #LAAO benefit high-risk non-#AFib patients after valvular surgery? Findings from the OPINION trial presented at #ESCCongress suggest no. 🚫 Read more: https://bit.ly/4g2GXAA

2025 High Blood Pressure Guideline-at-a-Glance: bit.ly/47tyqo6

#Hypertension #CardioSky #MedSky #JACC

“By weaving together cardiovascular prevention and heart failure care into one cohesive framework, clinicians can be EMPOWERED to take meaningful action at every stage—"

🔗 bit.ly/41Eafzy

#Prevention #JCF #MedicalPublishing #ContinuumOfCare #PreventativeCare

Are you passionate about improving #cardiovascular care for underserved communities? Apply by Oct. 15 for a new fellowship, offering funding ➕ support to a Fellow-in-Training or early-career in Mississippi, West Virginia, Florida or Seattle, WA.

Details ➡️ https://bit.ly/3Uprfpv #ACCHealthEquity

New 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults is here — developed with and endorsed by 12 leading organizations.

🫀 ow.ly/unFV50WGQFA

#CardioSky #MedSky @ajpcardio.bsky.social

Headshots of all the panelists during the Heart Talk with the Global Community during RISE @ ESC Congres 2025

What does real support for women in cardiology look like around the world? 🌍

At RISE @ ESC Congress 2025, cardiologists from 6 continents share local insights & solutions to advance women in the field.

Register now: rise.womenasone.org

#LetsRISE2025 #ESCCongress #WCCardio #CardioSky

The #CardioSmart High Blood Pressure Hub offers patients guidance for living w/ & monitoring high BP, including 📥 infographics on the basics of BP measurements & more.

Visit the hub & share these resources w/ your patients ➡️ https://bit.ly/45xjjaD

#Hypertension #CardioSky #MedSky

Figure 1 from JAMA, 'Management of Menopausal Symptoms': A clinical approach flowchart for prescribing menopausal hormone therapy. It details symptom assessment, contraindications, HT prep, and nonhormonal alternatives.

✅ Editor's choice: This review on #menopause offers insights into diagnosis and management strategies for vasomotor and genitourinary symptoms.

🔖 Bookmark it for your citations: ja.ma/4mI58Xd

JAMA Research Letter: Trends in US & International Medical Graduates at County Level. Figure 1 shows unadjusted mean physician count for USMGs/IMGs (2010-2022). USMG count higher than IMG. National mean count for both graduates increasing with time.

From 2010 to 2022, international medical graduates made up approximately 18% of the US #physician workforce, particularly in underserved urban areas, despite growing numbers of US medical graduates.

ja.ma/4lzGxTr #MedEd

This new experiment could take us closer to a theory of everything - BBC Science Focus Magazine

Good morning

Check out @drmarthagulati.bsky.social’s insights on the WARRIOR Trial

#ESCTVOnTheRoad #ACC245

When in Chicago you get the pipe bands by the best! #ACC25 @accintouch.bsky.social

HOST-BR trial: After stent implantation, a three-month regimen of DAPT was more effective than a one-month regimen at reducing adverse events without increasing bleeding risk in patients with a high bleeding risk. #ACC25

Read more: bit.ly/4hWqflL

#CardioSky #MedSky

💡 #Semaglutide is the first therapy to ⬇️ #MACE, improve cardiometabolic and kidney outcomes and improves walking capacity, symptoms, and related #QoL in patients with #cvPAD and #T2D

#ACC25 #JACCJournals #CardioSky

Figure 2. Cumulative Incidence of New-Onset Atrial Fibrillation or Atrial Flutter in Patients Randomized to Receive Finerenone or Placebo

From JAMA Cardiology: Finerenone was effective in heart failure patients with mildly reduced or preserved ejection fraction, regardless of atrial fibrillation (AF) status, and new-onset AF was linked to higher risk of adverse outcomes.

#ACC25 https://ja.ma/4iKwgDk

Extended anticoagulant therapy with reduced-dose apixaban was noninferior to full-dose in patients with active cancer and #cvVTE, based on findings from the API-CAT trial presented at #ACC25.

Read the journal scan to learn more: bit.ly/43w2A8v

#CardioSky #MedSky

Figure 1. Ten-Year Cumulative Incidence and Incidence Rate of Any Stroke After Transient Ischemic Attack or Minor Stroke

Patients who experience a transient ischemic attack (TIA) or minor stroke face a high risk of subsequent strokes, emphasizing the need for both short-term and long-term prevention strategies. https://ja.ma/4j1z6nd

The global CV community is gathering together at #ACC25! Hear from ACC.25 leaders on what’s 🆕, and learn about the lineup of LBCTs, inspiring Keynotes, the all-new Gameshow Room, the AI Intensive, and more not-to-miss meeting highlights in #CardiologyMag: bit.ly/41HVmg3

#CardioSky #MedSky

🆕 2025 ACC/AHA/ACEP/NAEMSP/SCAI ACS Guideline highlights the importance of the most recent clinical evidence in treating patients w/ heart attacks and other #cvACS.

Access the guideline here: bit.ly/4kmV7yz

@jaccjournals.bsky.social #ClinicalGuidelines #JACC #CardioSky #MedSky

Our editorial today in @usatoday.com
Funding Cuts at the #NIH will harm women and set back all the gains we have made in #womenscardiovascularhealth @womensheart.bsky.social @smidtheart.bsky.social
📎 www.usatoday.com/story/opinio...

In a contemporary population of patients w/ transthyretin amyloid cardiomyopathy (ATTR-CM) treated with tafamidis, long-term mortality was relatively high, according to a multicenter study published in #JACCCardioOnc.

More: bit.ly/4b2jm0J

#CardioOnc #MedSky #CardioSky @jaccjournals.bsky.social